These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36736734)

  • 1. Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus.
    Nunez Lopez YO; Iliuk A; Casu A; Parikh A; Smith JS; Corbin K; Lupu D; Pratley RE
    Diabetes Res Clin Pract; 2023 Mar; 197():110565. PubMed ID: 36736734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology.
    Nunez Lopez YO; Iliuk A; Petrilli AM; Glass C; Casu A; Pratley RE
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of serum-derived extracellular vesicles are associated with the severity and different clinical profiles of patients with COVID-19: An exploratory secondary analysis.
    Paes Leme AF; Yokoo S; Normando AGC; Ormonde JVS; Domingues RR; Cruz FF; Silva PL; Souza BSF; Dos Santos CC; Castro-Faria-Neto H; Martins CM; Lopes-Pacheco M; Rocco PRM
    Cytotherapy; 2024 May; 26(5):444-455. PubMed ID: 38363248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
    Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
    Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteome and phosphoproteome of circulating extracellular vesicle-enriched preparations are associated with characteristic clinical features in type 1 diabetes.
    Casu A; Nunez Lopez YO; Yu G; Clifford C; Bilal A; Petrilli AM; Cornnell H; Carnero EA; Bhatheja A; Corbin KD; Iliuk A; Maahs DM; Pratley RE
    Front Endocrinol (Lausanne); 2023; 14():1219293. PubMed ID: 37576973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.
    Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
    Front Endocrinol (Lausanne); 2021; 12():658304. PubMed ID: 34248840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
    Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
    Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
    Mao K; Tan Q; Ma Y; Wang S; Zhong H; Liao Y; Huang Q; Xiao W; Xia H; Tan X; Luo P; Xu J; Long D; Jin Y
    Cell Death Dis; 2021 May; 12(6):541. PubMed ID: 34035220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.
    Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thålin C
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):878-882. PubMed ID: 33267656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation.
    Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY
    Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
    Alzahrani FA; Shait Mohammed MR; Alkarim S; Azhar EI; El-Magd MA; Hawsawi Y; Abdulaal WH; Yusuf A; Alhatmi A; Albiheyri R; Fakhurji B; Kurdi B; Madani TA; Alguridi H; Alosaimi RS; Khan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
    Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A
    Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional causal associations between type 2 diabetes and COVID-19.
    Cao H; Baranova A; Wei X; Wang C; Zhang F
    J Med Virol; 2023 Jan; 95(1):e28100. PubMed ID: 36029131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome.
    Meidert AS; Hermann S; Brandes F; Kirchner B; Buschmann D; Billaud JN; Klein M; Lindemann A; Aue E; Schelling G; Pfaffl MW; Reithmair M
    Front Immunol; 2021; 12():784028. PubMed ID: 34956213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity.
    Aharon A; Dangot A; Kinaani F; Zavaro M; Bannon L; Bar-Lev T; Keren-Politansky A; Avivi I; Jacob G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.
    Islam MB; Chowdhury UN; Nain Z; Uddin S; Ahmed MB; Moni MA
    Comput Biol Med; 2021 Sep; 136():104668. PubMed ID: 34340124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Spike-Extracellular Vesicles (S-EVs) as a Tool to Mimic SARS-CoV-2 Interaction with Host Cells.
    Verta R; Grange C; Skovronova R; Tanzi A; Peruzzi L; Deregibus MC; Camussi G; Bussolati B
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective.
    Nunez Lopez YO; Casu A; Pratley RE
    Front Immunol; 2021; 12():617042. PubMed ID: 33968019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.